184 related articles for article (PubMed ID: 9414089)
1. The promyelocytic leukemia protein PML has a pro-apoptotic activity mediated through its RING domain.
Borden KL; CampbellDwyer EJ; Salvato MS
FEBS Lett; 1997 Nov; 418(1-2):30-4. PubMed ID: 9414089
[TBL] [Abstract][Full Text] [Related]
2. An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm.
Borden KL; Campbell Dwyer EJ; Salvato MS
J Virol; 1998 Jan; 72(1):758-66. PubMed ID: 9420283
[TBL] [Abstract][Full Text] [Related]
3. Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins.
Borden KL; Campbelldwyer EJ; Carlile GW; Djavani M; Salvato MS
J Virol; 1998 May; 72(5):3819-26. PubMed ID: 9557665
[TBL] [Abstract][Full Text] [Related]
4. Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival.
Fagioli M; Alcalay M; Tomassoni L; Ferrucci PF; Mencarelli A; Riganelli D; Grignani F; Pozzan T; Nicoletti I; Grignani F; Pelicci PG
Oncogene; 1998 Jun; 16(22):2905-13. PubMed ID: 9671411
[TBL] [Abstract][Full Text] [Related]
5. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA.
Lai HK; Borden KL
Oncogene; 2000 Mar; 19(13):1623-34. PubMed ID: 10763819
[TBL] [Abstract][Full Text] [Related]
6. The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML.
Borden KL; Boddy MN; Lally J; O'Reilly NJ; Martin S; Howe K; Solomon E; Freemont PS
EMBO J; 1995 Apr; 14(7):1532-41. PubMed ID: 7729428
[TBL] [Abstract][Full Text] [Related]
7. [Effects of PML and PML-RAR alpha antisense oligonucleotides on promyelocytic leukemia cell line NB4].
Chen Y; Miao J; Fang Z
Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):283-6. PubMed ID: 11778550
[TBL] [Abstract][Full Text] [Related]
8. Surface residue mutations of the PML RING finger domain alter the formation of nuclear matrix-associated PML bodies.
Boddy MN; Duprez E; Borden KL; Freemont PS
J Cell Sci; 1997 Sep; 110 ( Pt 18)():2197-205. PubMed ID: 9378769
[TBL] [Abstract][Full Text] [Related]
9. The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E.
Kentsis A; Dwyer EC; Perez JM; Sharma M; Chen A; Pan ZQ; Borden KL
J Mol Biol; 2001 Sep; 312(4):609-23. PubMed ID: 11575918
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of a RNA-dependent nuclear interaction between the promyelocytic leukaemia protein and glyceraldehyde-3-phosphate dehydrogenase.
Carlile GW; Tatton WG; Borden KL
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):691-6. PubMed ID: 9794812
[TBL] [Abstract][Full Text] [Related]
11. The promyelocytic leukemia protein stimulates SUMO conjugation in yeast.
Quimby BB; Yong-Gonzalez V; Anan T; Strunnikov AV; Dasso M
Oncogene; 2006 May; 25(21):2999-3005. PubMed ID: 16501610
[TBL] [Abstract][Full Text] [Related]
12. Serum-dependent expression of promyelocytic leukemia protein suppresses propagation of influenza virus.
Iki S; Yokota S; Okabayashi T; Yokosawa N; Nagata K; Fujii N
Virology; 2005 Dec; 343(1):106-15. PubMed ID: 16154611
[TBL] [Abstract][Full Text] [Related]
13. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
[TBL] [Abstract][Full Text] [Related]
14. PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu.
Liu JH; Mu ZM; Chang KS
J Exp Med; 1995 Jun; 181(6):1965-73. PubMed ID: 7759992
[TBL] [Abstract][Full Text] [Related]
15. Ret finger protein is a normal component of PML nuclear bodies and interacts directly with PML.
Cao T; Duprez E; Borden KL; Freemont PS; Etkin LD
J Cell Sci; 1998 May; 111 ( Pt 10)():1319-29. PubMed ID: 9570750
[TBL] [Abstract][Full Text] [Related]
16. Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML.
Ahn JH; Brignole EJ; Hayward GS
Mol Cell Biol; 1998 Aug; 18(8):4899-913. PubMed ID: 9671498
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues.
Gambacorta M; Flenghi L; Fagioli M; Pileri S; Leoncini L; Bigerna B; Pacini R; Tanci LN; Pasqualucci L; Ascani S; Mencarelli A; Liso A; Pelicci PG; Falini B
Am J Pathol; 1996 Dec; 149(6):2023-35. PubMed ID: 8952536
[TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML.
Borden KL; Lally JM; Martin SR; O'Reilly NJ; Solomon E; Freemont PS
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1601-6. PubMed ID: 8643677
[TBL] [Abstract][Full Text] [Related]
19. The promyelocytic leukemia protein represses A20-mediated transcription.
Wu WS; Xu ZX; Chang KS
J Biol Chem; 2002 Aug; 277(35):31734-9. PubMed ID: 12080044
[TBL] [Abstract][Full Text] [Related]
20. Opposing effects of PML and PML/RAR alpha on STAT3 activity.
Kawasaki A; Matsumura I; Kataoka Y; Takigawa E; Nakajima K; Kanakura Y
Blood; 2003 May; 101(9):3668-73. PubMed ID: 12506013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
